ClinicalTrials.Veeva

Menu

The Role of a Private Hospital in Hong Kong Amid COVID-19 Pandemic

H

HKSH Medical Group

Status

Completed

Conditions

COVID

Treatments

Diagnostic Test: COVID 19 Diagnostic Test

Study type

Observational

Funder types

Industry

Identifiers

NCT04416061
RC-2020-08

Details and patient eligibility

About

Hong Kong public healthcare system is facing tremendous pressure under the COVID-19 pandemic. As the virus spread in Hong Kong, Hong Kong Sanatorium & Hospital (HKSH) is one of the first private hospitals which immediately provide reliable and rapid COVID-19 test -- Reverse Transcription Polymerase Chain Reaction (RT-PCR). Early provision of the RT-PCR screening test for COVID-19 not only facilitates identification of COVID-19 but also contains the spread of the virus in the community and frontline medical staff.

Since description of role of private hospital in Hong Kong amid COVID-19 pandemic is lacking, this study will describe COVID-19 screening algorithm and methodology. A retrospective analysis on clinical characteristics, laboratory findings as well as outcome of patients who underwent COVID-19 test in HKSH is also performed.

Enrollment

2,510 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subjects who underwent COVID-19 test in HKSH during the study period

Exclusion criteria

Trial design

2,510 participants in 1 patient group

Subjects underwent COVID-19 test
Description:
Subjects who underwent COVID-19 test in HKSH during the study period
Treatment:
Diagnostic Test: COVID 19 Diagnostic Test

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems